Document is current
Any future updates will be listed below
-
Authors
Degli Esposti, Michelle https://orcid.org/0000-0002-0068-5754
Ziauddeen, Hisham
Bowes, Lucy
Reeves, Aaron
Chekroud, Adam M.
Humphreys, David K.
Ford, Tamsin
- License Information
-
More Information
Article History
Received: 19 July 2021
Accepted: 5 December 2021
First Online: 24 December 2021
Declarations
:
: Dr. Chekroud reports other from Spring Care Inc, other from Fitbit Inc, from UnitedHealthcare Inc, outside the submitted work. In addition, Dr. Chekroud has a patent submission for three major depressive disorder treatments pending to a) USPTO docket number Y0087.70116US00, b) USPTO. Provisional Appl. No. 62/491,660, and c) USPTO. Provisional Appl. No. 62/629,041, and has consulted for Fortress Biotech on antidepressant drug development. All other authors have no relevant financial or non-financial interests to disclose.
: Ethical approval was not required, because all data were fully anonymised, pre-published, and publicly available.
